Selection for pentobarbital withdrawal severity: Correlated differences in withdrawal from other sedative drugs

Christopher L. Kliethermes, Pamela Metten, John Belknap, Kari Buck, John Jr Crabbe

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

In mice, withdrawal from agents that depress central nervous system function, such as barbiturates and benzodiazepines, results in the production of a withdrawal syndrome, one feature of which is increased severity of handling induced convulsions (HICs). High and Low Pentobarbital Withdrawal mice (HPW and LPW) were selectively bred to display severe and mild pentobarbital withdrawal HICs, respectively. These mice provide a valuable means to assess genetic correlations between withdrawal from pentobarbital and other sedative agents. We tested HPW and LPW mice for severity of HICs elicited during withdrawal from ethanol, diazepam, and zolpidem, and measured consumption of and preference for pentobarbital solutions in HPW and LPW mice. HPW mice displayed greater HICs than LPW mice during ethanol and zolpidem withdrawal, but differed less robustly during diazepam withdrawal. LPW mice consumed more pentobarbital in a solution of a moderate concentration than did HPW mice, but did not consume more pentobarbital at a higher or lower concentration. These results indicate that some of the same genes that affect the severity of withdrawal from pentobarbital also influence ethanol and zolpidem withdrawal, but that diazepam withdrawal may be less influenced by these genes.

Original languageEnglish (US)
Pages (from-to)17-25
Number of pages9
JournalBrain Research
Volume1009
Issue number1-2
DOIs
StatePublished - May 29 2004

Fingerprint

Pentobarbital
Hypnotics and Sedatives
Pharmaceutical Preparations
Seizures
Diazepam
Ethanol
Central Nervous System Agents
Barbiturates
Benzodiazepines
Genes

Keywords

  • Barbiturate
  • Benzodiazepine
  • Drugs of abuse: alcohol, barbiturates, and benzodiazepines
  • Genetics
  • Neural basis of behavior
  • Pentobarbital withdrawal

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Selection for pentobarbital withdrawal severity : Correlated differences in withdrawal from other sedative drugs. / Kliethermes, Christopher L.; Metten, Pamela; Belknap, John; Buck, Kari; Crabbe, John Jr.

In: Brain Research, Vol. 1009, No. 1-2, 29.05.2004, p. 17-25.

Research output: Contribution to journalArticle

Kliethermes, Christopher L. ; Metten, Pamela ; Belknap, John ; Buck, Kari ; Crabbe, John Jr. / Selection for pentobarbital withdrawal severity : Correlated differences in withdrawal from other sedative drugs. In: Brain Research. 2004 ; Vol. 1009, No. 1-2. pp. 17-25.
@article{eda78af9edeb4f5997851791d66abb4c,
title = "Selection for pentobarbital withdrawal severity: Correlated differences in withdrawal from other sedative drugs",
abstract = "In mice, withdrawal from agents that depress central nervous system function, such as barbiturates and benzodiazepines, results in the production of a withdrawal syndrome, one feature of which is increased severity of handling induced convulsions (HICs). High and Low Pentobarbital Withdrawal mice (HPW and LPW) were selectively bred to display severe and mild pentobarbital withdrawal HICs, respectively. These mice provide a valuable means to assess genetic correlations between withdrawal from pentobarbital and other sedative agents. We tested HPW and LPW mice for severity of HICs elicited during withdrawal from ethanol, diazepam, and zolpidem, and measured consumption of and preference for pentobarbital solutions in HPW and LPW mice. HPW mice displayed greater HICs than LPW mice during ethanol and zolpidem withdrawal, but differed less robustly during diazepam withdrawal. LPW mice consumed more pentobarbital in a solution of a moderate concentration than did HPW mice, but did not consume more pentobarbital at a higher or lower concentration. These results indicate that some of the same genes that affect the severity of withdrawal from pentobarbital also influence ethanol and zolpidem withdrawal, but that diazepam withdrawal may be less influenced by these genes.",
keywords = "Barbiturate, Benzodiazepine, Drugs of abuse: alcohol, barbiturates, and benzodiazepines, Genetics, Neural basis of behavior, Pentobarbital withdrawal",
author = "Kliethermes, {Christopher L.} and Pamela Metten and John Belknap and Kari Buck and Crabbe, {John Jr}",
year = "2004",
month = "5",
day = "29",
doi = "10.1016/j.brainres.2004.02.040",
language = "English (US)",
volume = "1009",
pages = "17--25",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Selection for pentobarbital withdrawal severity

T2 - Correlated differences in withdrawal from other sedative drugs

AU - Kliethermes, Christopher L.

AU - Metten, Pamela

AU - Belknap, John

AU - Buck, Kari

AU - Crabbe, John Jr

PY - 2004/5/29

Y1 - 2004/5/29

N2 - In mice, withdrawal from agents that depress central nervous system function, such as barbiturates and benzodiazepines, results in the production of a withdrawal syndrome, one feature of which is increased severity of handling induced convulsions (HICs). High and Low Pentobarbital Withdrawal mice (HPW and LPW) were selectively bred to display severe and mild pentobarbital withdrawal HICs, respectively. These mice provide a valuable means to assess genetic correlations between withdrawal from pentobarbital and other sedative agents. We tested HPW and LPW mice for severity of HICs elicited during withdrawal from ethanol, diazepam, and zolpidem, and measured consumption of and preference for pentobarbital solutions in HPW and LPW mice. HPW mice displayed greater HICs than LPW mice during ethanol and zolpidem withdrawal, but differed less robustly during diazepam withdrawal. LPW mice consumed more pentobarbital in a solution of a moderate concentration than did HPW mice, but did not consume more pentobarbital at a higher or lower concentration. These results indicate that some of the same genes that affect the severity of withdrawal from pentobarbital also influence ethanol and zolpidem withdrawal, but that diazepam withdrawal may be less influenced by these genes.

AB - In mice, withdrawal from agents that depress central nervous system function, such as barbiturates and benzodiazepines, results in the production of a withdrawal syndrome, one feature of which is increased severity of handling induced convulsions (HICs). High and Low Pentobarbital Withdrawal mice (HPW and LPW) were selectively bred to display severe and mild pentobarbital withdrawal HICs, respectively. These mice provide a valuable means to assess genetic correlations between withdrawal from pentobarbital and other sedative agents. We tested HPW and LPW mice for severity of HICs elicited during withdrawal from ethanol, diazepam, and zolpidem, and measured consumption of and preference for pentobarbital solutions in HPW and LPW mice. HPW mice displayed greater HICs than LPW mice during ethanol and zolpidem withdrawal, but differed less robustly during diazepam withdrawal. LPW mice consumed more pentobarbital in a solution of a moderate concentration than did HPW mice, but did not consume more pentobarbital at a higher or lower concentration. These results indicate that some of the same genes that affect the severity of withdrawal from pentobarbital also influence ethanol and zolpidem withdrawal, but that diazepam withdrawal may be less influenced by these genes.

KW - Barbiturate

KW - Benzodiazepine

KW - Drugs of abuse: alcohol, barbiturates, and benzodiazepines

KW - Genetics

KW - Neural basis of behavior

KW - Pentobarbital withdrawal

UR - http://www.scopus.com/inward/record.url?scp=2142821387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2142821387&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2004.02.040

DO - 10.1016/j.brainres.2004.02.040

M3 - Article

C2 - 15120579

AN - SCOPUS:2142821387

VL - 1009

SP - 17

EP - 25

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -